FDA to Limit Industry Employees From Its Advisory Committees

The FDA plans to limit individuals employed by FDA-regulated companies, such as pharmaceutical firms, from serving as official members on its advisory committees.

• “While the FDA should be partnering with industry to ensure a user-friendly review process, the scientific evaluation of new products should be independent,” FDA Commissioner Martin Makary said in a statement.
• Having industry employees serve as official members of FDA advisory committees “represents a cozy relationship that is concerning to many Americans,” Makary said

To view the source of this information, click here

To contact the reporter on this story:
Hari Govind in San Francisco at hgovind@bloomberg.net ...